|
The result was announced after market hours on Wednesday, 25 January 2017.
Meanwhile, the S&P BSE Sensex was up 246.10 points or 0.89% at 27,954.24.
On the BSE, 56,000 shares were traded on the counter so far as against the average daily volumes of 58,581 shares in the past one quarter. The stock had hit a high of Rs 625 and a low of Rs 605 so far during the day.
The stock had hit a record high of Rs 694.80 on 20 December 2016 and a 52-week low of Rs 171.10 on 29 February 2016. The stock had underperformed the market over the past one month till 25 January 2017, declining 3.67% compared with the Sensex's 6.4% rise. The scrip had, however, outperformed the market over the past one quarter, advancing 29.44% as against the Sensex's 1.36% fall.
The small-cap company has equity capital of Rs 19.50 crore. Face value per share is Rs 10.
Astec Lifesciences total income from operations rose 94.81% to Rs 62.38 crore in Q3 December 2016 over Q3 December 2015.
Astec is a producer of agrochemicals and pharmaceutical intermediates.
|